The big picture: Clementine, a Maastricht-based startup, has raised €1.7 million in Seed funding for its AI-powered platform designed to help hearing clinics convert leads into patients. The company, also known as ClementineAI, aims to transform how individuals with hearing loss engage with healthcare. Learn more at Clementine.
Why it matters:
- Untreated Hearing Loss: An estimated 1.5 billion people worldwide suffer from hearing loss, with nearly 80% never seeking treatment, often waiting over eight years.
- Patient Barriers: Traditional hearing care faces challenges in addressing emotional and practical barriers, leading to significant delays in seeking help.
- Clinic Efficiency: Hearing clinics struggle with administrative burdens and ensuring every patient inquiry receives a timely and effective response.
How it works:
- AI Hearing Agent: Clementine’s platform features Matthew, an AI hearing care agent that engages directly with prospective patients 24/7.
- Comprehensive Support: Matthew answers questions, educates users, and helps overcome common barriers without judgment or waiting lists, guiding them towards appropriate care.
- Streamlined Operations: For clinics, the AI agent reduces administrative work by translating patient inquiries into bookings, improving staff efficiency and patient flow.
The catch: While AI offers significant potential for improving access to hearing care, integrating such technology into existing clinic workflows and building patient trust in AI for sensitive health issues will be critical. The market for healthtech AI is also becoming increasingly competitive, requiring Clementine to continuously innovate and demonstrate clear value.
Key Facts
- Company: Clementine
- Amount: €1.7M
- Round: Seed
- Investor: Healthy.Capital (lead)
- Founder: Vince van de Weijer
- Announced: 2026-08-28
- Sector: AI-powered Hearing Care Platform
- Headquarters: Maastricht, Netherlands
